Your browser doesn't support javascript.
loading
A Novel Multi-Component Formulation Reduces Inflammation In Vitro and Clinically Lessens the Symptoms of Chronic Eczematous Skin.
Kim, Jihee; Jung, Eunjoong; Yang, Wonmi; Kim, Chun-Kang; Durnaoglu, Serpen; Oh, In-Rok; Kim, Chan-Wha; Sinskey, Anthony J; Mihm, Martin C; Lee, Ju Hee.
  • Kim J; Department of Dermatology & Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Jung E; Scar Laser and Plastic Surgery Center, Yonsei Cancer Hospital, Seoul 03722, Republic of Korea.
  • Yang W; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Kim CK; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Durnaoglu S; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Oh IR; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Kim CW; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Sinskey AJ; Biocoz Global Korea, R & D Center, Seoul 03181, Republic of Korea.
  • Mihm MC; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Lee JH; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Int J Mol Sci ; 24(16)2023 Aug 19.
Article en En | MEDLINE | ID: mdl-37629159
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Eccema Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Eccema Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article